首页> 外国专利> Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene

Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene

机译:磺酰胺取代的稠合7环化合物,其用作包含该化合物的药物和药物制剂的用途

摘要

Benzoxepine and benzocycloheptane derivatives of formula (I), their stereoisomers and salts are new. X1 = O, S, SO, SO2, CR1R2, NR6, CO or CR1R7; R1, R2 = H, CF3, C2F5, C3F7, 1-6C alkyl or phenyl (optionally substituted by 1 or 2 of halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me; or R1+R2 = 2-10C alkylene; R6 = H or CnH2nR8 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR9 or CONR9; R9 = H or 1-4C alkyl; n = 0-8; R8 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NMe2, NEt2, piperidino, pyrrolidino, morpholino, 4-methyl-1-piperazinyl or pyridyl, thienyl, imidazolyl or phenyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); X2 = CR1R2 or CR2R10; or X2 = O, S, SO, SO2 or NR6 if X3 and X1 are CR1R2; R10+R7 = bond; X3 = CR1R2; or X3 = O, S, SO, SO2 or NR6 if X2 and X4 are CR1R2; X4 = CR1R2, NR6, NR11, CH(OR30) or CR2R11; R30 = H, 1-3C alkyl or 1-4C acyl; R11+R5 = bond; Y1-Y4 = CR12 or N with no more than two being N; R12 = H, halo, 1-5C alkyl, 3-8C cycloalkyl, CN, CF3, C2F5, C3F7, N3, NO2, ZCmH2mR13 or phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); Z = O, CO, COO, OCO, S, SO, SO2, SO2NR14, NR14 or CONR14; R14 = H or 1-3C alkyl; m = 0-6; R13 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR15R16, CONR15R16, OR30a or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R15, R16 = H or 1-3C alkyl; or R15+R16 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); R30a = H, 1-3C alkyl or 1-4C acyl; or Y1+Y2 = S and Y3, Y4 = CR12; R3 = NR18CxH2xR17 or CxH2xR17 (with one CH2 group optionally replaced by O, CO, S, SO, SO2 or NR19); R19 = H, Me or Et; R17 = H, Me, 3-8C cycloalkyl, CF3, C2F5 or C3F7; x = 0-10; R18 = H or 1-8C alkyl; or R18+R17 = bond if x = 3-10; or R3 = phenyl (optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); or R3+R4 = 3-8C alkylene (with one CH2 optionally replaced by O, CO, S, SO or SO2); R4 = CrH2rR20 (with one CH2 group optionally replaced by O, CH=CH, C IDENTICAL C, CO, COO, OCO, S, SO, SO2, NR21 or CONR21); R21 = H or 1-3C alkyl; r = 0-20; R20 = H, CF3, C2F5, C3F7, 3-8C cycloalkyl, NR22R23 or phenyl, thienyl or 1-9C N-containing heterocyclyl (all optionally substituted by 1 or 2 halo, CF3, NO2, CN, NH2, OH, Me, Et, OMe, NMe2, SO2NH2, SO2Me and NHSO2Me); R22, R23 = H or 1-3C alkyl; or R22+R23 = 4-5C methylene (with one carbon optionally replaced by O, S, NH, NMe or N(benzyl)); and R5 = H; or R5+R11 = bond.
机译:式(I)的苯并氧平和苯并环庚烷衍生物,其立体异构体和盐是新的。 X1 = O,S,SO,SO2,CR1R2,NR6,CO或CR1R7; R1,R2 = H,CF3,C2F5,C3F7、1-6C烷基或苯基(可选地被卤素,CF3,NO2,CN,NH2,OH,Me,Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me;或R1 + R2 = 2-10C亚烷基; R6 = H或CnH2nR8(其中一个CH2基团可选地被O,CH = CH,C标识的C,CO,COO,OCO,S,SO,SO2,NR9或CONR9取代; R9 = H或1-4C烷基; n = 0-8; R8 = H,CF3,C2F5,C3F7、3-8C环烷基,NMe2,NEt2,哌啶子基,吡咯烷基,吗啉代,4-甲基-1-哌嗪基或吡啶基,噻吩基,咪唑基或苯基(均可选地被1或2个卤素,CF3,NO2,CN,NH2,OH,Me,Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me取代); X2 = CR1R2或CR2R10;或X2 =如果X3和X1为CR1R2,则O,S,SO,SO2或NR6; R10 + R7 =键; X3 = CR1R2;或者如果X2和X4为CR1R2,则X3 = O,S,SO,SO2或NR6; X4 = CR1R2,NR6 ,NR11,CH(OR30)或CR2R11; R30 = H,1-3C烷基或1-4C酰基; R11 + R5 =键; Y1-Y4 = CR12或N,其中N不超过两个; R12 = H,卤素,1-5C烷基,3-8C环烷基,CN,CF3,C2F5,C3F7,N3,NO2,ZCmH2mR13或苯基(可选被1或2个卤素,CF3,NO2,CN,NH2,OH,Me,Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me取代); Z = O,CO,COO,OCO,S,SO,SO2,SO2NR14,NR14或CONR14; R14 = H或1-3C烷基; m = 0-6; R13 = H,CF3,C2F5,C3F7、3-8C环烷基,NR15R16,CONR15R16,OR30a或苯基,噻吩基或1-9C含氮杂环基(全部可选地被1或2个卤素取代,CF3,NO2,CN,NH2, OH,Me,Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me); R15,R16 = H或1-3C烷基;或R 15 + R 16 = 4-5C亚甲基(一个碳任选地被O,S,NH,NMe或N(苄基)取代);或R 30a = H,1-3C烷基或1-4C酰基;或Y1 + Y2 = S和Y3,Y4 = CR12; R3 = NR18CxH2xR17或CxH2xR17(带有一个CH2基团,可选地被O,CO,S,SO,SO2或NR19取代); R19 = H,Me或Et; R17 = H,Me,3-8C环烷基,CF3,C2F5或C3F7; x = 0-10; R18 = H或1-8C烷基;如果x = 3-10,则R18 + R17 =键;或R3 =苯基(任选地被1或2个卤素,CF3,NO2,CN,NH2,OH,Me,Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me取代);或或R 3 + R 4 = 3-8C亚烷基(其中一个CH 2任选被O,CO,S,SO或SO 2取代);或R4 = CrH2rR20(带有一个CH2基团,可选地被O,CH = CH,C,C,CO,COO,OCO,S,SO,SO2,NR21或CONR21取代); R21 = H或1-3C烷基; r = 0-20; R20 = H,CF3,C2F5,C3F7、3-8C环烷基,NR22R23或苯基,噻吩基或1-9C含N的杂环基(均可选被1或2个卤素,CF3,NO2,CN,NH2,OH,Me, Et,OMe,NMe2,SO2NH2,SO2Me和NHSO2Me); R22,R23 = H或1-3C烷基;或R22 + R23 = 4-5C亚甲基(其中一个碳任选地被O,S,NH,NMe或N(苄基)取代);或并且R5 = H;或R5 + R11 =键。

著录项

  • 公开/公告号NO980785A

    专利类型

  • 公开/公告日1998-08-27

    原文格式PDF

  • 申请/专利权人 HOECHST AG;

    申请/专利号NO19980000785

  • 申请日1998-02-25

  • 分类号C07D313/08;C07C311/07;A61K31/335;

  • 国家 NO

  • 入库时间 2022-08-22 02:57:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号